Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM

Harvard Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
91.4M 94.14M 97.73M 101.13M 106.79M 112.25M 112.52M 114.08M 114.53M 113.33M 117.96M 120.7M 120.69M 118.9M 116.83M 111.21M 105.32M
Cost of Revenue
40.55M 42.03M 44.7M 46.13M 47.01M 47.57M 46.95M 51.06M 51.54M 52.52M 53.42M 52.02M 52.3M 51.25M 51.03M 48.22M 44.83M
Gross Profit
50.85M 52.1M 53.03M 54.99M 59.78M 64.68M 65.58M 63.02M 62.99M 60.82M 64.55M 68.68M 68.4M 67.65M 65.8M 62.99M 60.49M
Operating Income
-43.76M -5M -4.72M -3.78M -1.17M 1.89M 1.16M -2.22M -3.96M -12.42M -10.26M -5.41M -4.41M 2.07M 3.12M 2.76M 3.25M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-57.98M -11.66M -13.36M -9.43M -8.25M -2.56M -2.35M -6.47M -954K -9.18M -7.16M -2.42M -6.47M -140K -1.82M -3.28M -3.52M
Net Income
-58.05M -12.4M -14.24M -10.68M -8.73M -3.42M -3.26M -5.43M -2.01M -9.52M -6.89M -3.65M -6.5M -288K -1.86M -2.79M -3.96M
Selling & General & Admin
41.99M 43.7M 45.01M 45.99M 46.44M 46.89M 47.19M 47.8M 48.83M 49.53M 51.18M 50.68M 50.24M 48.95M 46.64M 44.99M 42.81M
Research & Development
9.84M 10.41M 11.23M 11.42M 11.75M 11.76M 11.46M 11.47M 12.01M 12.33M 12.43M 12.33M 11.53M 10.8M 10.2M 9.49M 8.68M
Other Expenses
42.77M 2.85M 1.37M -97K -469K 1.06M 2.69M 4.22M 6.04M 4.73M 2.92M 1.21M -554K -666K -811K -1.07M -951K
Operating Expenses
94.61M 57.1M 57.75M 58.77M 60.95M 62.79M 64.42M 65.24M 66.88M 67.98M 69.56M 68.84M 67.61M 65.59M 62.68M 60.23M 57.23M
Interest Expense
1.66M 3.21M 3.15M 3.18M 3.37M 3.59M 3.7M 3.56M 3.14M 2.55M 2.03M 1.65M 1.51M 1.54M 2.25M 3.09M 3.94M
Selling & Marketing Expenses
21.28M 22.21M 23.04M 23.25M 24.03M 24.11M 23.84M 23.92M 24.33M 25.04M 26.44M 26.8M 25.94M 24.64M 22.77M 21.17M 19.72M
Cost & Expenses
131.02M 94.99M 102.46M 104.91M 107.95M 110.36M 111.37M 116.3M 118.43M 120.5M 122.97M 120.86M 119.91M 116.84M 113.71M 108.45M 102.06M
Income Tax Expense
76K 740K 883K 1.25M 484K 859K 918K -1.04M 1.06M 337K -267K 1.23M 25K 148K 45K -487K 448K
Shares Outstanding (Basic)
44.1M 43.54M 43.61M 43.49M 43.4M 42.71M 42.69M 42.35M 42.12M 42.1M 41.64M 41.3M 40.47M 40.84M 40.75M 40.15M 39.79M
Shares Outstanding (Diluted)
44.1M 43.54M 43.61M 43.49M 43.4M 42.71M 42.69M 42.35M 42.78M 42.1M 41.64M 42.56M 41.22M 43.37M 40.75M 40.15M 39.79M
EPS (Basic)
-1.32 -0.29 -0.33 -0.25 -0.2 -0.08 -0.08 -0.13 -0.05 -0.23 -0.17 -0.1 -0.16 -0.01 -0.05 -0.07 -0.1
EPS (Diluted)
-1.32 -0.29 -0.33 -0.25 -0.2 -0.08 -0.08 -0.13 -0.05 -0.23 -0.17 -0.1 -0.16 -0.01 -0.05 -0.07 -0.1
EBITDA
-39.57M -1.77M -3.46M -742K 595K 6.34M 8.36M 5.51M 5.89M -2.37M -1.9M 2.63M 3.34M 9.76M 10.63M 9.83M 10.59M
EBIT
-4.72M -8.46M -10.21M -6.25M -2.93M 2.56M 2.87M -1.39M -3.07M -11.45M -9.43M -4.84M -4.22M 2.14M 666K 500K 1.12M
Depreciation & Amortization
5.33M 7.07M 7.08M 7.05M 7.01M 6.99M 7.18M 7.34M 7.45M 7.58M 7.54M 7.48M 7.56M 7.62M 7.15M 6.65M 6.19M